T-cell activation is an immune correlate of risk in BCG vaccinated infants

Citations Over TimeTop 1% of 2016 papers

Abstract

Vaccines to protect against tuberculosis (TB) are urgently needed. We performed a case-control analysis to identify immune correlates of TB disease risk in Bacille Calmette-Guerin (BCG) immunized infants from the MVA85A efficacy trial. Among 53 TB case infants and 205 matched controls, the frequency of activated HLA-DR(+) CD4(+) T cells associates with increased TB disease risk (OR=1.828, 95% CI=1.25-2.68, P=0.002, FDR=0.04, conditional logistic regression). In an independent study of Mycobacterium tuberculosis-infected adolescents, activated HLA-DR(+) CD4(+) T cells also associate with increased TB disease risk (OR=1.387, 95% CI=1.068-1.801, P=0.014, conditional logistic regression). In infants, BCG-specific T cells secreting IFN-γ associate with reduced risk of TB (OR=0.502, 95% CI=0.29-0.86, P=0.013, FDR=0.14). The causes and impact of T-cell activation on disease risk should be considered when designing and testing TB vaccine candidates for these populations.

Related Papers

• Association of Colonoscopy and Death From Colorectal Cancer: A Population-Based, Case-Control Study(2009)
• → Vaccine Efficacy of a Lysine Auxotroph of Mycobacterium tuberculosis(2003)81 cited
• → Protective immunity afforded by attenuated, PhoP‐deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T‐cell memory(2011)47 cited
• → The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy(2022)15 cited
• [A case-control study on risk factors of cerebral hemorrhage].(1992)